| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/30/2014 | US20140030275 A-beta binding polypeptides |
| 01/30/2014 | US20140030273 Human antibodies and antibody-drug conjugates against cd74 |
| 01/30/2014 | US20140030265 Modified soluble fgf receptor fc fusions method |
| 01/30/2014 | US20140030262 Materials and methods for evaluating and treating neuromyelitis optica (nmo) |
| 01/30/2014 | US20140030260 Methods and compositions to eliminate chronic lymphocytic leukemia and other hematologic malignant cells in stromal microenvironment for cancer therapy |
| 01/30/2014 | US20140030256 Benzoxazole kinase inhibitors and methods of use |
| 01/30/2014 | US20140030253 HUMANIZED FORMS OF MONOCLONAL ANTIBODIES TO HUMAN GnRH RECEPTOR |
| 01/30/2014 | US20140030249 Pharmaceutical Compositions |
| 01/30/2014 | US20140030233 Therapeutic Compositions and Methods |
| 01/30/2014 | US20140030229 New clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer |
| 01/30/2014 | US20140030228 Methods and Compositions of Biocontrol of Plant Pathogens |
| 01/30/2014 | US20140030227 Therapeutic amoeba and uses thereof |
| 01/30/2014 | US20140030226 Prevention and treatment of ocular side effects with a cyclosporin |
| 01/30/2014 | US20140030224 Methods and pharmaceutical compositions for inhibiting influenza viruses replication |
| 01/30/2014 | US20140030223 Inhibitors of flaviviridae viruses |
| 01/30/2014 | US20140030221 Macrocyclic inhibitors of flaviviridae viruses |
| 01/29/2014 | EP2689782A1 Improving memory in subjects with mini-mental state examination of 24-26 |
| 01/29/2014 | EP2688648A1 A 5-ht4 receptor agonist as a prokinetic agent |
| 01/29/2014 | EP2688593A2 S1p antagonists as adjunct ocular hypotensives |
| 01/29/2014 | EP2688575A2 Lithium compositions |
| 01/29/2014 | EP2688572A1 A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof. |
| 01/29/2014 | EP2688570A2 6-substituted estradiol derivatives for use in remyelination of nerve axons |
| 01/29/2014 | EP2688565A1 Treatment of proliferative disorders with a chemiluminescent agent |
| 01/29/2014 | EP2688402A1 Methods for treating or preventing urological inflammation |
| 01/29/2014 | EP2410857B1 P2x3, receptor antagonists for treatment of pain |
| 01/29/2014 | EP2181709B1 Synergic combination of analgesic compounds |
| 01/29/2014 | EP1790637B1 Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient |
| 01/29/2014 | EP1539122B1 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 01/29/2014 | CN103547284A Immunity inducing agent |
| 01/29/2014 | CN103547282A Therapeutic agent for alopecia |
| 01/29/2014 | CN103547258A Topical nitric oxide systems and methods of use thereof |
| 01/29/2014 | CN103540654A Applications of 11-19 lysine-rich leukemia (ELL) gene and expression product thereof |
| 01/29/2014 | CN103540653A Applications of homeobox A1 (HOXA1) gene and expression product thereof |
| 01/29/2014 | CN103540651A Nanometer gold complex as well as preparation and application thereof |
| 01/29/2014 | CN103536925A Application of cardiac glycoside compound in treatment of non-small cell lung cancer |
| 01/29/2014 | CN103536924A Methods of using GPR119 receptor to identify compounds useful for increasing bone mass in an individual |
| 01/29/2014 | CN103536923A Formulations for enhanced bioavailability of orally administered polar agents |
| 01/29/2014 | CN103536922A Application of acyl-coenzyme A: cholesterol acyltransferase-2 (ACAT2) inhibitor in liver cancer growth inhibition |
| 01/29/2014 | CN103536921A Application of cholesterol metabolite for inhibiting liver cancer growth |
| 01/29/2014 | CN103536920A Pharmaceutical composition for inhibiting pancreatic cancer cell proliferation and application thereof |
| 01/29/2014 | CN103536916A Methods for treating tweak-related conditions |
| 01/29/2014 | CN103536906A Use of pegylated Type III Interferons for the treatment of hepatitis C |
| 01/29/2014 | CN103536596A Transdermal delivery of diclofenac, carbamazepine and benzydamine |
| 01/29/2014 | CN102895665B Preparation method of targeting graphene nano-grade drug carrier |
| 01/29/2014 | CN101909649B Compositions and methods for treating asthma and lung disorders |
| 01/29/2014 | CN101400406B Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 01/28/2014 | US8637469 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
| 01/28/2014 | US8637451 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/28/2014 | US8637051 Compositions and methods for treatment of mucosal infections |
| 01/28/2014 | US8637029 Methods for the treatment of gout |
| 01/28/2014 | US8636997 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist |
| 01/28/2014 | US8636988 Composition for treatment of sunburned skin |
| 01/28/2014 | US8636979 TLR 4 and 9 receptors agonists for preventing septic complications of post-traumatic immunodepression in patients hospitalized for severe traumatic injuries |
| 01/28/2014 | CA2618974C Nanoemulsion compositions having anti-inflammatory activity |
| 01/28/2014 | CA2556870C Dopamine-agonist combination therapy for improving sleep quality |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/28/2014 | CA2510315C Antibodies against gpr64 and uses thereof |
| 01/28/2014 | CA2484318C Warming and nonirritating lubricant antifungal gel compositions |
| 01/28/2014 | CA2464867C Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 01/28/2014 | CA2431916C New therapeutic uses of smr1 peptides |
| 01/23/2014 | WO2014015183A1 Ophthalmic formulation and method for ameliorating presbyopia |
| 01/23/2014 | WO2014014960A1 Treating of epilepsy and alcohol addiction with creatine |
| 01/23/2014 | WO2014014845A1 Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases |
| 01/23/2014 | WO2014014841A1 Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof |
| 01/23/2014 | WO2014014766A1 Krill oil and reacted astaxanthin composition and associated method |
| 01/23/2014 | WO2014012954A1 Treatment of partly controlled or uncontrolled severe asthma |
| 01/23/2014 | WO2014012935A1 Substituted aminoindane- and aminotetralincarboxylic acids and use thereof |
| 01/23/2014 | WO2014012902A2 Melanosome transport inhibition for the treatment of melanoma |
| 01/23/2014 | WO2013188763A9 Compositions for treating cancer and methods for making the same |
| 01/23/2014 | US20140024725 Modulators for trpa1 for the treatment of rosacea |
| 01/23/2014 | US20140024710 5-aminolevulinic acid derivatives, methods for their preparation and uses thereof |
| 01/23/2014 | US20140024702 Cancer gene therapy using nucleic acids encoding us28 and g-protein |
| 01/23/2014 | US20140024695 Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 01/23/2014 | US20140024693 Topical composition |
| 01/23/2014 | US20140024683 Chloride channel and chloride transporter modulators for therapy in smooth muscle diseases |
| 01/23/2014 | US20140024675 Crystalline forms of a prolyl hydroxylase inhibitor |
| 01/23/2014 | US20140024672 Azaindole derivatives as cftr modulators |
| 01/23/2014 | US20140024671 Compositions and methods for inhibiting cytochrome p450 |
| 01/23/2014 | US20140024663 Atb(0,+) amino acid transporter as a drug target for treatment of estrogen receptor-positive breast cancer |
| 01/23/2014 | US20140024652 Substituted triazolophthalazine derivatives |
| 01/23/2014 | US20140024648 New pyridazinone and pyridone compounds |
| 01/23/2014 | US20140024639 Compounds, Compositions, and Methods for Cancer Therapy |
| 01/23/2014 | US20140024638 Treatment of cognitive dysfunction in schizophrenia |
| 01/23/2014 | US20140024628 Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as a medicament and the preparation thereof |
| 01/23/2014 | US20140024624 Method of Ameliorating Clotting Pathologies and Related Materials and Methods |
| 01/23/2014 | US20140024617 Treatment of cancer with complex organic-inorganic pigment compositions |
| 01/23/2014 | US20140024613 Methods for Treating HCV |
| 01/23/2014 | US20140024607 Ngna compositions and methods of use |
| 01/23/2014 | US20140024594 Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 01/23/2014 | US20140024588 Method for inducing sustained immune response |
| 01/23/2014 | US20140024587 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 01/23/2014 | US20140024585 Composition for the therapy of diabetes mellitus and adiposity |
| 01/23/2014 | US20140024584 Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| 01/23/2014 | US20140024583 Organic compounds |
| 01/23/2014 | US20140024576 Heptose derivatives for use in the treatment of bacterial infections |
| 01/23/2014 | US20140023717 Methods and compositions for treating proliferative diseases |
| 01/23/2014 | US20140023699 Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration |
| 01/23/2014 | US20140023692 Drug delivery device |
| 01/23/2014 | US20140023677 Herbal compositions for treating neurological diseases and improving memory impairment |
| 01/23/2014 | US20140023668 C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |